Background: Chronic Bronchitis has been proposed by GOLD as a phenotype of pre-COPD. Besides,
chronic bronchitis has consistently been linked to increased decline in FEV1. Recently,
an analysis of the Copenhagen Health Study linked chronic bronchitis to development
of COPD. Therefore, we investigated associations of chronic bronchitis with FEV1 decline
and development of COPD in the German population-based cohort KORA.
Methods: 2255 individuals from KORA were analysed for signs of chronic cough and/or expectoration.
Patients came from two groups, one with n=1320, aged 41 – 62 years, the other with
n=935, aged 65 – 90 years. Spirometry data were analyzed with healthy lung function
status defined as FEV1/FVC>0.7 and>10th percentile, as well as FEV1 and FVC% pred.>80%, and COPD defined as FEV1/FVC<0.7
and<lower limit of normal. Chronic bronchitis was assessed as patient-reported presence
of chronic cough with expectoration for at least three months per year. Patients were
followed over a period of 3.5 – 7 years.
Results: In the higher age group, chronic cough and expectoration was associated with an
increased risk for high yearly FEV1 decline (> 100 ml, OR 2.3 [1.42 – 3.72], p<0.001),
but not a spirometry result consistent with development of COPD. Simultaneously, no
such association was found in younger individuals. Generally, most patients with chronic
cough or expectoration did not display airflow obstruction, PRISM or early airflow
limitation, defined as FEV1/FVC>0.7 and<10th percentile or FEV1/FVC<0.7 and in range of 5th to 10th percentile. Spirometry values of patients with chronic cough and/or expectoration
displayed no clustering pattern when compared to COPD or at-risk for COPD subgroups.
Conclusion: In a population-based cohort of middle-aged and older individuals, chronic cough
and/or expectoration were in the majority associated with normal lung function status.
Chronic bronchitis symptoms did not predict development of COPD during follow-up.
However, presence of cough/and or bronchitis was significantly associated with increased
FEV1 decline in elder individuals.